Cell transformation by v-Rel reveals distinct roles of AP-1 family members in Rel/NF-kappaB oncogenesis

A S Liss1, R Tiwari, J Kralova

  • 1Section of Molecular Genetics and Microbiology, Institute of Cellular and Molecular Biology, University of Texas at Austin, Austin, TX 78712-1095, USA.

Oncogene
|June 22, 2010
PubMed

Insights

The v-Rel oncogene drives cell transformation by altering AP-1 gene expression, with Fos/Jun heterodimers being key. Understanding these AP-1 proteins, like ATF2 and c-Fos, is crucial for Rel/NF-kappaB oncogenesis research.

Area of Science:

  • Oncogenesis
  • Molecular Biology
  • Cell Signaling

Background:

  • Cell transformation involves aberrant gene expression regulated by Rel/NF-kappaB family members.
  • The specific roles of individual AP-1 proteins in v-Rel oncogene-mediated transformation are not well understood.

Purpose of the Study:

  • To investigate the contribution of individual AP-1 proteins to v-Rel-mediated cell transformation.
  • To elucidate the regulatory mechanisms of AP-1 proteins induced by v-Rel.

Main Methods:

  • Analysis of gene and protein expression in v-Rel-transformed cells.
  • Utilizing a c-Jun dimerization mutant to assess Fos/Jun heterodimer function.
  • Investigating ATF2 regulation and its impact on signaling pathways.
  • Assessing the role of Ha-Ras as a v-Rel effector.

Main Results:

  • v-Rel transformation elevates c-Fos, c-Jun, and ATF2 expression while repressing Fra-2.
  • c-Fos and c-Jun, particularly Fos/Jun heterodimers, are essential for v-Rel transformation.
  • ATF2 is required but its overexpression is inhibitory; it engages in a positive feedback loop involving p38 MAPK.
  • Ha-Ras is identified as a v-Rel effector, and ATF2 inhibits the Ras-Raf-MEK-ERK pathway.

Conclusions:

  • AP-1 proteins, especially Fos/Jun heterodimers, play critical and complex roles in v-Rel-mediated oncogenesis.
  • v-Rel utilizes distinct mechanisms to regulate AP-1 members, including direct gene upregulation and pathway activation.
  • ATF2 has a novel inhibitory role in the Ras-Raf-MEK-ERK pathway, highlighting its multifaceted function in oncogenesis.

Related Concept Videos

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...